Randgold Resources: Changes to the board and board

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
151
Randgold Resources: Changes to the board and board committees

JERSEY, CHANNEL ISLANDS--(Marketwired - May 2, 2017) - Randgold Resources ( LSE : RRS ) ( NASDAQ : GOLD )

RANDGOLD RESOURCES LIMITED Incorporated in Jersey, Channel Islands Reg. No. 62686 LSE Trading Symbol: RRS NASDAQ Trading Symbol: GOLD ("Randgold Resources" or the "Company")

CHANGES TO THE BOARD AND BOARD COMMITTEES

Jersey, Channel Islands, 2 May 2017  - Following the annual general meeting held on 2 May 2017, and as announced on 3 February 2017, Kadri Dagdelen, a non-executive director and a member of the Company's governance & nomination committee retired from the board on 2 May 2017. 

Randgold Resources also announces that with effect from 2 May 2017, Olivia Kirtley, a non-executive director has been appointed a member of the audit committee. Also effective 2 May 2017, Jeanine Mabunda Lioko, a non-executive director, has been appointed a member of the governance and nomination committee, and will step down from the audit committee.

Commenting on the changes, Randgold Resources' Chairman, Christopher Coleman, said: "These changes strengthen the board's committees following recent changes to the board. I would like to thank Kadri for his contribution as a Randgold non-executive director. He has been a source of guidance for the business in particular to the mining teams over the past seven years. "

RANDGOLD RESOURCES ENQUIRIES:

Chief Executive Mark Bristow +44 788 071 1386 +44 779 775 2288   Financial Director Graham Shuttleworth +44 1534 735 333 +44 779 771 1338   Investor & Media Relations Kathy du Plessis +44 20 7557 7738 Email: randgold@dpapr.com

Website: www.randgoldresources.com

Contact: RNS Customer Services 0044-207797-4400 rns@londonstockexchange.com http://www.rns.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

iCapital Enhances Portfolio Solutions For Global Investors

Updated Category News Views 267

iCapital Enhances Portfolio Construction Tools for Investors iCapital, a leading global fintech platform, has introduced significant enhancements to its innovative portfolio construction tool, iCapital Architect. This advanced platform is designed to simplify the integration of alternative investments into traditional portfolio strategies. Financial advisors gain access...

Continue Reading
Market Adaptability: S&P 500 Faces Correction Ahead

Updated Category News Views 210

Understanding Recent Market Movements The market experienced a turbulent session recently, sending investors into a state of caution. This volatility was significantly influenced by renewed discussions around tariffs impacting trade relationships, particularly involving technology and manufacturing sectors. The Impact of Tariffs on the Market Former President Trump's...

Continue Reading
Performance Systems Integration Merges with Summit Fire & Security

Updated Category News Views 177

Performance Systems Integration Merger with Summit Fire & Security Performance Systems Integration (PSI), recognized as the leading fire and life safety solutions provider in the Pacific Northwest, has completed a merger with Summit Fire & Security LLC, which is a subsidiary of SFP Holding, Inc. This merger marks a significant collaboration that aims to enhance the safety...

Continue Reading
Candel Therapeutics Shares Optimistic Findings on CAN-3110

Updated Category News Views 159

Revealing Interim Results from Candel Therapeutics NEEDHAM, Mass. — Candel Therapeutics, Inc. (Nasdaq: CADL), a biopharmaceutical company dedicated to advancing biological immunotherapies to combat cancer, has announced noteworthy interim data stemming from its ongoing phase 1b clinical trial of CAN-3110 (linoserpaturev) targeting recurrent glioblastoma. This...

Continue Reading
Supernus Pharmaceuticals Reaches New Heights with Strong Growth

Updated Category News Views 83

Supernus Pharmaceuticals Hits Record Stock Levels Supernus Pharmaceuticals Inc (NASDAQ: SUPN) has achieved a remarkable milestone, as its stock recently surged to a 52-week high of $35.45. This significant increase showcases the company’s strong financial performance and growth prospects, creating a wave of optimism among investors. The stock has risen an impressive...

Continue Reading